Bruno Poddevin
Impact in
- Biotechnology top 0.5%
- Microbial Inactivation Methods
-
- Cancer therapeutics and mechanisms
- DNA and Nucleic Acid Chemistry
- Cell death mechanisms and regulation
Papers in
-
- Microbial Inactivation Methods 4
-
- Cancer therapeutics and mechanisms 2
- DNA and Nucleic Acid Chemistry 1
- Co-authors
- Jean Belehradek (6 shared papers)Lluis M. Mir (6 shared papers)Stéphane Orlowski (5 shared papers)Claude Paoletti (1 shared paper)Yves G. Pommier (2 shared papers)L.H. Ramirez (1 shared paper)Jean‐François Riou (1 shared paper)François Lavelle (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Biochemical Pharmacology (2 papers)Biochimica et Biophysica Acta (BBA) - Biomembranes (1 paper)Molecular Pharmacology (1 paper)European Journal of Cancer and Clinical Oncology (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
Bruno Poddevin
9 papers receiving 734 citations
Peers
Comparison fields: 5 of 28
- Biotechnology 429
- Molecular Biology 111
- Pulmonary and Respiratory Medicine 53
- Pharmaceutical Science 9
- Biophysics 7
Countries citing papers authored by Bruno Poddevin
This map shows the geographic impact of Bruno Poddevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Poddevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Poddevin more than expected).
Fields of papers citing papers by Bruno Poddevin
This network shows the impact of papers produced by Bruno Poddevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Poddevin. The network helps show where Bruno Poddevin may publish in the future.
Co-authors
The 12 scholars most cited alongside Bruno Poddevin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 200 | |
| 2 | 1991 | 148 | |
| 3 | 1994 | 122 | |
| 4 | 1999 | 114 | |
| 5 | Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. | 1992 | 91 |
| 6 | 1993 | 73 | |
| 7 | 1994 | 27 | |
| 8 | 1994 | 14 | |
| 9 | 1990 | 13 |
About Bruno Poddevin
Bruno Poddevin is a scholar working on Biotechnology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 9 papers that have together received 802 indexed citations. Recurring topics across this work include Microbial Inactivation Methods (4 papers), Cancer therapeutics and mechanisms (2 papers), Radiopharmaceutical Chemistry and Applications (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). The work is most often cited by research in Biotechnology (429 citations), Molecular Biology (111 citations), Pulmonary and Respiratory Medicine (53 citations), Pharmaceutical Science (9 citations) and Biophysics (7 citations). Bruno Poddevin has collaborated with scholars based in France and United States. Frequent co-authors include Jean Belehradek, Lluis M. Mir, Stéphane Orlowski, Claude Paoletti, Yves G. Pommier, L.H. Ramirez, Jean‐François Riou, François Lavelle, Omar Tounekti and Marc Vasseur. Their work appears in journals such as Biochemical and Biophysical Research Communications, Biochemical Pharmacology, Biochimica et Biophysica Acta (BBA) - Biomembranes, Molecular Pharmacology and European Journal of Cancer and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.